Abstract: A system for reconfiguring a seating assembly within a vehicle, the system comprising identifying an adjacent surface within an interior of the vehicle, calculating a distance between the seating assembly and the adjacent surface, wherein the configuration is an occupiable seating configuration, and further wherein the occupiable seating configuration has a mode chosen from a forward facing mode and a rearward facing mode, storing the distance between the seating assembly and the adjacent surface, receiving a user input to transition the seating assembly from one occupiable seating configuration mode chosen from the forward facing mode and the rearward facing mode toward the other mode, and controlling the configuration of the seating assembly to transition from one occupiable seating configuration mode chosen from the forward facing mode and the rearward facing mode toward the other of the forward facing mode and the rearward facing mode.

Abstract: A headrest assembly includes a lattice matrix having a plurality of three-dimensional (3D) cells. Each 3D cell of includes a node and a plurality of links outwardly extending from the node. The lattice matrix includes a plurality of sections including a first section having a first overall elastic modulus, a second section positioned adjacent to the first section and having a second overall elastic modulus that is higher than the first overall elastic modulus of the first section, and a third section positioned adjacent to the second section and having a third overall elastic modulus that is higher than the second overall elastic modulus of the second section. The lattice matrix is integrally constructed using an additive manufacturing technique, wherein the 3D cells of each section are provided in various patterns and cured to varying degrees to provide the varying overall elastic moduli of each section of the lattice matrix.

Abstract: Aspects of the invention are directed to arginine-free polypeptide-containing compositions and methods for treating disorders associated with inflammation or the autoimmune response. In particular, the polypeptide is etanercept.

Abstract: Aspects of the invention are directed to arginine-free polypeptide-containing compositions and methods for treating disorders associated with inflammation or the autoimmune response. In particular, the polypeptide is etanercept.

Abstract: Aspects of the invention are directed to arginine-free polypeptide-containing compositions and methods for treating disorders associated with inflammation or the autoimmune response. In particular, the polypeptide is etanercept.

Abstract: The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, episodic (on-demand) treatment, or perioperative management of hemophilia.

Abstract: The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, episodic (on-demand) treatment, or perioperative management of hemophilia.

Abstract: A system for secure transactions of information is provided herein, where the system includes a computing device having a software application installed thereon and is configured to store a public cryptocurrency key and a hardware encryption device configured to store a private encryption key, and is configured to selectively connect in data communication to the computing device for signing an cryptocurrency transaction. The computing device broadcasts a signed transaction received from the hardware encryption device for verification of the transaction.

Abstract: This invention relates to a new and distinctive variety of a Malus xdomestica apple tree named ‘NY109’, particularly characterized by its overall superior horticultural performance and consistency, including excellent fruit quality at harvest by having firm, juicy, high sugar and high acid and flavorful fruit with great potential for marketing as both a fresh apple and as value-added processed apple products, such as for hard and sweet cider and for baking, is disclosed.

Abstract: A new and distinctive variety of a Malus domestica apple tree named ‘NY56’, particularly characterized by its overall horticultural performance and consistency including resistance to apple scab and excellent fruit quality at harvest by having crisp, juicy and flavorful fruit, is disclosed.

Abstract: The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, episodic (on-demand) treatment, or perioperative management of hemophilia.

Abstract: The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, episodic (on-demand) treatment, or perioperative management of hemophilia.

Abstract: Formulations of VLA-4 binding antibody are described.

Abstract: Systems and methods are disclosed herein for synthesizing ammonia using nano-size metal or metal alloy catalyst particles. Hydrogen and nitrogen gases are passed through a system comprising, for example, a bed of magnetite supporting nano-size iron or iron alloy catalyst particles having an optional oxide layer that forms the catalyst.

Abstract: Systems and methods are disclosed herein for synthesizing ammonia using nano-size metal or metal alloy catalyst particles. Hydrogen and nitrogen gases are passed through a system comprising, for example, a bed of magnetite supporting nano-size iron or iron alloy catalyst particles having an optional oxide layer that forms the catalyst.

Abstract: The disclosed invertible structures rely on combinations of translational movements to effect inversion. An exemplary invertible structure includes a track operable to be slidably coupled to at least two connectors of a longitudinal structure. The track may have a slot having a plurality of translational axes for translational movements of the connectors of the longitudinal structure that would effect the inversion of the longitudinal structure.

Abstract: A new and distinctive variety of a Malus domestica apple tree named ‘NY56’, particularly characterized by its overall horticultural performance and consistency including resistance to apple scab and excellent fruit quality at harvest by having crisp, juicy and flavorful fruit, is disclosed.

Abstract: This invention relates to a new and distinctive variety of a Malus x domestica apple tree named ‘NY109’, particularly characterized by its overall superior horticultural performance and consistency, including excellent fruit quality at harvest by having firm, juicy, high sugar and high acid and flavorful fruit with great potential for marketing as both a fresh apple and as value-added processed apple products, such as for hard and sweet cider and for baking, is disclosed.

Abstract: A new and distinctive variety of a Malus x domestica apple tree named ‘NY73’, particularly characterized by its attractive fruit appearance, unique pink blush, overall superior horticultural performance and consistency, including excellent fruit quality at harvest by having firm, crisp, juicy, and flavorful fruit with great potential for marketing as both a fresh apple and in u-pick, retail, and wholesale operations is disclosed.